secwatch.observer — SEC 8-K summary
======================================

Issuer:     CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
CIK:        0001187953
Form:       8-K
Filed at:   2022-02-11T23:59:59+00:00
Accession:  0001477932-22-000691
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Creative Medical enters new 3-year employment agreements with CEO and CFO
-------------------------------------------------------------------------

- CEO Warbington base salary $330,000/year; CFO Dickerson $300,000/year.
- Each eligible for annual cash bonus targeted at 30% of base salary.
- Annual option grant valued at 30% of base salary, vesting over 3 years (25% immediate, then annual).
- Severance: if terminated without cause or for good reason, 2 years of base salary plus bonuses.
- Employment agreements have 3-year initial term with automatic renewal for successive 3-year periods.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1187953/000147793222000691/0001477932-22-000691-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1187953/000147793222000691/celz_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-22-000691

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer